On April 17, 2024, in connection with the determination by the Board of Directors of Soleno Therapeutics, Inc. at the Company?s 2024 Annual Meeting of Stockholders Gwen Melincoff, a current director, notified the Company that she does not intend to stand for re-election to the Board at the 2024 AGM.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.66 USD | +2.28% | +8.51% | +13.44% |
Jun. 06 | Transcript : Soleno Therapeutics, Inc. - Shareholder/Analyst Call | |
Jun. 04 | Soleno Therapeutics to Join Russell 3000 Index | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.44% | 1.63B | |
+18.94% | 125B | |
+14.05% | 108B | |
-4.50% | 24.57B | |
+3.09% | 22.82B | |
-10.44% | 18.19B | |
-41.48% | 16.54B | |
-12.28% | 16.5B | |
+2.99% | 13.39B | |
+27.39% | 11.1B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Soleno Therapeutics, Inc. Announces Gwen Melincoff, Intends Not Intend to Stand for Re-Election as Director